2003
DOI: 10.1159/000070278
|View full text |Cite
|
Sign up to set email alerts
|

Gender Differences in Methamphetamine-Induced mRNA Associated with Neurodegeneration in the Mouse Nigrostriatal Dopaminergic System

Abstract: In this report female and male CD-1 mice were treated with a neurotoxic regimen of methamphetamine (MA) to compare gender differences in striatal dopamine depletion and concordant changes in mRNA markers of the transforming growth factor-β injury response associated with neurodegeneration. Striatal dopamine concentrations of MA-treated female mice were less depleted and significantly greater than that of identically treated males. Associated with this gender difference in striatal dopamine depletion were signi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
29
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 42 publications
(32 citation statements)
references
References 34 publications
3
29
0
Order By: Relevance
“…In MPTP models of PD, female mice have been reported to be more resistant to the dopaminedepleting effects of the toxin (Disshon and Dluzen, 2000;Dluzen, 1996;Dluzen et al, 1996;Dluzen et al, 2003;Freyaldenhoven et al, 1996;Miller et al, 1998;Nishino et al, 1998;Tamas et al, 2005). Similarly, male rats show greater susceptibility to toxicity of 6-OHDA when measured either by depletion of dopaminergic neurons or by behavioral recovery (Cass et al, 2005;Datla et al, 2003;Gillies et al, 2004;Murray et al, 2003;Tamas et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…In MPTP models of PD, female mice have been reported to be more resistant to the dopaminedepleting effects of the toxin (Disshon and Dluzen, 2000;Dluzen, 1996;Dluzen et al, 1996;Dluzen et al, 2003;Freyaldenhoven et al, 1996;Miller et al, 1998;Nishino et al, 1998;Tamas et al, 2005). Similarly, male rats show greater susceptibility to toxicity of 6-OHDA when measured either by depletion of dopaminergic neurons or by behavioral recovery (Cass et al, 2005;Datla et al, 2003;Gillies et al, 2004;Murray et al, 2003;Tamas et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…As glial response is associated with hypermetabolism (Roh et al, 1998), the absence of frontal hypometabolism in female MA users in the current study may be associated with enhanced glial repair response to MA in females rather than males. After MA exposure, female mice have been reported to express augmented mRNA of glial fibrillary acidic protein, which is associated with glial repair response to brain injury (Dluzen et al, 2003;Garcia-Segura et al, 1999).…”
Section: Discussionmentioning
confidence: 99%
“…One important implication related to this issue is that of NSDA neurodegeneration and neurotoxicity. When treated with equivalent doses of neurotoxins which target the NSDA system, the degree of neurodegeneration observed in males is significantly greater than that in female as obtained in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [7,8,9], 6-hydroxydopamine [10, 11] and the psychostimulant methamphetamine (MA) [12,13,14,15,16,17,18,19]. …”
Section: Introductionmentioning
confidence: 99%
“…First, notable gender differences in use and characteristics of response to MA have been reported [20]. Second, since high doses and/or repeated treatment can produce neurodegeneration of the NSDA system, the significantly greater amount of striatal dopamine (DA) depletion in response to MA treatment within male mice [12,13,14,15,16,17,18,19] may serve to model NSDA neurodegenerative conditions like Parkinson’s disease, which also generally shows a higher incidence in males [21,22,23,24,25]. Third, the degree of toxicity to MA differs between male and female mice, as mortality rates to MA are greater in males [26].…”
Section: Introductionmentioning
confidence: 99%